Laminin α2 chain-deficient congenital muscular dystrophy: Variable epitope expression in severe and mild cases

Neurology

Volumn 51, Issue 1, 1998, Pages 94-100

  Cohn, Ronald D ^b   Herrmann, R ^c   Sorokin, L ^a   Wewer, U M ^c   Voit, Thomas ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MEROSIN; ANTIBODY; LAMININ; LAMININ ALPHA2; LAMININ S;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFANT; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; ADULT; BASEMENT MEMBRANE; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IN VITRO STUDY; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; PROTEIN TERTIARY STRUCTURE;

ADULT; ANTIBODIES; BASEMENT MEMBRANE; CHILD, PRESCHOOL; EPITOPES; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; INFANT; INFANT, NEWBORN; LAMININ; MUSCULAR DYSTROPHIES; PHENOTYPE; PROTEIN STRUCTURE, TERTIARY;

EID: 0031594943     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.94     Document Type: Article

References (48)

1. Dubowitz V. Muscle disorders of childhood. 2nd ed. London: Saunders, 1995.
2. Dubowitz V. Workshop report on 22nd ENMC sponsored meeting on congenital muscular dystrophy held in Baarn, The Netherlands, May 14-16 1993. Neuromusc Disord 1994;4:75-81.
3. Dubowitz V, Fardeau M. Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy April 22-24 1994, The Netherlands. Neuromusc Disord 1995;5:253-258.
4. Tomé FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci Paris Life Sci 1994;317:351-357.
5. Sewry C, Philpot J, Mahony D, et al. Expression of laminin subunits in congenital muscular dystrophy. Neuromusc Disord 1995;5:307-316.
6. Fardeau M, Tome FMS, Helbling-Leclerc A, et al. Dystrophie musculaire congenitale avec deficience en merosine. Rev Neurol (Paris) 1996;152:11-19.
7. Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 1995;5:301-305.
8. Mercuri E, Muntoni F, Berardinelli A, et al. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status. Neuropediatrics 1995;26:3-7.
9. Shorer Z, Philpot J, Muntoni F, Sewry C, Dubowitz V. Peripheral nerve involvement in congenital muscular dystrophy. J Child Neurol 1995;10:472-475.
10. Herrmann R, Straub V, Meyer K, Kahn T, Wagner M, Voit T. Congenital muscular dystrophy with laminin α2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry. Eur J Pediatr 1996;155:968-976.
11. Nissinen M, Helbling-Leclerc A, Zhang X, et al. Substitution of a conserved cysteine 996 in a cysteine rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am J Hum Genet 1996;58: 1177-1184.
12. Mora M, Moroni I, Uziel G, et al. Mild clinical phenotype in a 12 year old boy with a partial merosin deficiency and central and peripheral nervous system abnormalities. Neuromusc Disord 1996;6:377-381.
13. Tan E, Topaloglu H, Sewry C, et al. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency. Neuromusc Disord 1997;7:85-91.
14. Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin α-2 chain gene (LAMA2) cause merosin deficient congenital muscular dystrophy. Nat Genet 1995;11: 216-218.
15. Guicheney P, Vignier N, Helbling-Leclerc A, et al. Genetics of laminin α2 chain (or merosin) deficient congenital muscular dystrophy: from identification of mutations to prenatal diagnosis. Neuromusc Disord 1997;7:180-186.
16. Allamand V, Sunada Y, Salih MAM, et al. Mild congenital muscular dystrophy in two patients with an internally deleted laminin α2-chain. Hum Mol Genet 1997;6:747-752.
17. Cohn RD, Herrmann R, Wewer UM, Voit T. Changes of laminin β2 chain expression in congenital muscular dystrophy. Neuromusc Disord 1997;7:373-378.
18. Hayashi YK, Engvall E, Arikawa-Hirasawa E, et al. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci 1993;119:53-64.
19. Haltia M, Leivo I, Somer H, et al. Muscle-eye-brain disease: a neuropathological study. Ann Neurol 1997;41:173-180.
20. Wewer UM, et Engvall E. Merosin/laminin-2 and muscular dystrophy. Neuromusc Disord 1996;6:409-418.
21. Vuolteenaho R, Nissinen M, Sainio K, et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 1994;124:381-394.
22. Engvall E, Wewer UM. Domains of laminin. J Cell Biochem 1996;61:493-501.
23. Ehrig K, Leivo I, Argraves WS, Ruoslahti E, Engvall E. Merosin, a tissue specific membrane protein, is a laminin-like protein. Proc Natl Acad Sci USA 1990;87:3264-3268.
24. Paullson M, Saladin K, Engvall E. Structure of laminin variants. J Biol Chem 1991;266:17545-17551.
25. Sewry CA, Naom I, Dálessandro M, et al. Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin α2 chain. Neuromusc Disord 1997; 7:169-175.
26. Dubowitz V. Muscle biopsy: a practical approach. 2nd ed. London: Baillière, Tindall, 1985.
27. Voit T, Sewry CA, Meyer K, et al. Preserved merosin M chain (or laminin α2) expression in skeletal muscle membrane distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy. Neuropediatrics 1995;26:148-155.
28. Leivo I, Engvall E. Merosin. A protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast is expressed late in nerve and muscle development. Proc Natl Acad Sci USA 1988;85:1544-1548.
29. Hillaire D, Leclerc A, Fauré S, et al. Localization of merosin negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Human Mol Genet 1994;3;1657-1661.
30. Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem 1994; 269:13729-13732.
31. Xu H, Wu XR, Wewer UM, Engvall E. Murine muscular dystrophy caused by a mutation in the laminin alpha2 (LAMA2) gene. Nat Genet 1994;8:297-302.
32. Sunada Y, Bernier SM, Utani A, Yamada Y, Campbell KP. Identification of a novel mutant transcript of laminin alpha2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice. Hum Mol Genet 1995;4:1055-1061.
33. Yamada H, Shimizu T, Tanaka T, et al. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett 1994;352:49-53.
34. Campbell KP. Three muscular dystrophies: loss of cytoskeletal extracellular matrix linkage. Cell 1995;80:675-679.
35. Hayashi YK, Ishihara T, Domen K, Hori H, Arahata K. A benign allelic form of laminin α2 chain deficient muscular dystrophy. Lancet 1997;349:1147. Letter.
36. Voit T, Fardeau M, Tome FMS. Prenatal detection of merosin expression in human palcenta. Neuropediatrics 1994;25:332-333.
37. Muntoni F, Sewry C, Wilson L, et al. Prenatal diagnosis in congenital muscular dystrophy. Lancet 1995;345:591.
38. Zhang X, Vuolteenaho R, Tryggvason K. Structure of the human laminin α2-chain gene (LAMA2) which is affected in congenital muscular dystrophy. J Biol Chem 1996;271:27664-27669.
39. Pegoraro E, Mancias P, Swerdlow SH, et al. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy. Ann Neurol 1996;40:782-791.
40. Engvall E, Earwicker D, Day A, Muir D, Manthorpe M, Paulsson M. Merosin promotes cell attachment and neurite outgrowth and is a component of the neurite-promoting factor of RN22 Schwannoma cells. Exp Cell Res 1992;198:115-123.
41. Villanova M, Maladrini A, Toti P, et al. Localization of merosin in normal human brain: implications for congenital muscular dystrophy with merosin deficiency. J Submicrosc Cytol Pathol 1996;28:1-4.
42. Engvall E, Davis GE, Dickerson K, Ruoslahti E, Varon S, Manthorpe M. Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site. J Cell Biol 1986;103:2457-2465.
43. Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, Sanes JR. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regulation 1990;1:731-740.
44. Miner JH, Patton BL, Lentz SI, et al. The laminin α chains: expression, developmental transitions, and chromosomal locations of α 1-5, identification of heterotrimeric laminins 8-11,and cloning of a novel α3 isoform. J Cell Biol 1997;137: 685-701.
45. Tiger CF, Champliaud MF, Pedrosa-Domellof F, et al. Presence of laminin α5 chain and lack of laminin α1 chain during human muscle development and in muscular dystrophies. J Biol Chem 1997;272:28590-28595.
46. Tachi N, Ohya K, Chiba S, Matsuo M, Patria SY, Matsumura K. Deficiency of syntrophin, dystroglycan, and merosin in a female infant with a congenital muscular dystrophy phenotype lacking cysteine-rich and C-terminal domains of dystrophin. Neurology 1997;9:579-583.
47. Noakes PG, Gautam M, Mudd J, Sanes JR, Merlie JP. Aberrant differentiation of neuromuscular junctions in mice lacking α-laminin/laminin β2. Nature 1995;374:258-262.
48. Schuler F, Sorokin LM. Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. J Cell Sci 1995;108: 3795-3804.